Related Experiment Video
Updated: Jul 11, 2026
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Restricted field IMRT dramatically enhances IMRT planning for mesothelioma
Aaron M Allen1, Deborah Schofield, Fred Hacker
1Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. aallen@lroc.harvard.edu
International Journal of Radiation Oncology, Biology, Physics
|September 26, 2007
Summary
Restricted field intensity-modulated radiotherapy (IMRT) improves lung dose sparing for mesothelioma patients after extrapleural pneumonectomy without compromising target coverage. This novel technique enhances treatment safety and efficacy.
Area of Science:
- Radiation Oncology
- Thoracic Oncology
- Medical Physics
Background:
- Mesothelioma treatment after extrapleural pneumonectomy presents challenges for radiotherapy planning.
- Intensity-modulated radiotherapy (IMRT) is a standard treatment, but normal tissue sparing remains a concern.
Purpose of the Study:
- To enhance target coverage and normal tissue sparing in IMRT for mesothelioma post-extrapleural pneumonectomy.
- To evaluate a novel restricted field technique for improved radiotherapy delivery.
Main Methods:
- Thirteen mesothelioma patient IMRT plans were re-optimized using a restricted field technique.
- The technique limited beam angles to 200 degrees and restricted field apertures near critical organs.
- New constraints included mean lung dose <9.5 Gy and V5 Gy <55%.
Main Results:
- Restricted field IMRT maintained excellent planning target volume coverage (average 97%).
- Significant reductions in mean lung dose (6.6 Gy vs. 13.8 Gy), V20 Gy (3.0% vs. 15%), and V5 Gy (50.8% vs. 90%) were observed (p < 0.0001).
- Critical organs like the heart and kidneys remained within tolerance limits.
Conclusions:
- Restricted field IMRT offers an improved method for treating mesothelioma after extrapleural pneumonectomy.
- This technique enhances normal tissue sparing while maintaining target coverage.
- Further validation is planned through an upcoming Phase I trial.
